Tam co-founded SinoVeda in 2006 and is President and Chief Scientific Officer. He is the lead inventor of the Pharmaceutical Platform Technology®, which enables the development of multi-active, multi-target pharmaceutical products.

Prior to SinoVeda, Tam was the founder of the Kinetana Group of Companies and Novokin Biotech Inc., the former eventually being listed on the Hong Kong Stock Exchange. Prior to these organizations, Tam acted as a consultant to international pharmaceutical and biotechnology companies, and as a Visiting Professor for Roche in Basel, Switzerland.

Tam started his professional career as a Professor of Pharmacokinetics in the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta. He is the lead inventor of four patents, has co-authored over 100 book chapters and journal papers and is an invited speaker at international conferences, universities and workshops for multinational pharmaceutical companies. He is currently an Editorial Advisory Board Member of Drug Metabolism and Disposition and the Journal of Pharmaceutical Sciences. He is also a member of the Proof of Principle Committee, Canadian Institute of Health Research.

Tam holds a B.S. in Biology from the University of Minnesota, as well as an M.Sc. and Ph.D. in Pharmaceutical Sciences, both from the University of British Columbia.

Back to About Us